Human Reproductive Technologies

Human Reproductive Technologies Market by Type (Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination), Application (Fertility Preservation, Genetic Screening, Infertility Treatment), End-User - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the human reproductive technologies market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[183 Pages Report] The Human Reproductive Technologies Market size was estimated at USD 29.84 billion in 2023 and expected to reach USD 31.82 billion in 2024, at a CAGR 6.66% to reach USD 46.89 billion by 2030.

Human Reproductive Technologies Market
To learn more about this report, request a free PDF copy
Human Reproductive Technologies Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Reproductive Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Reproductive Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Reproductive Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aurobindo Pharma, Bayer AG, CooperSurgical Fertility Solutions, Eli Lilly and Company, European Sperm Bank, Evofem Biosciences, Inc., Ferring B.V., GSK PLC, InSEM Fertility Solutions, INVO Bioscience, KG Medical Industries, Mankind Pharma, Merck KGaA, Microm UK Ltd., Monash IVF Group, Pfizer Inc., Pride Angel, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., V Conceive, Vitrolab AB, and Voxtur Bio Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Reproductive Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Assisted Reproductive Technology
    • In Vitro Fertilizartion
    • Intrauterine Insemination
    • Preimplantation Genetic Testing
    • Surrogacy
  • Application
    • Fertility Preservation
    • Genetic Screening
    • Infertility Treatment
  • End-User
    • Fertility Clinics
    • Hospitals
    • Research & Academic Institutes

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Human Reproductive Technologies Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Reproductive Technologies Market?
  3. What are the technology trends and regulatory frameworks in the Human Reproductive Technologies Market?
  4. What is the market share of the leading vendors in the Human Reproductive Technologies Market?
  5. Which modes and strategic moves are suitable for entering the Human Reproductive Technologies Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Human Reproductive Technologies Market, by Type
  7. Human Reproductive Technologies Market, by Application
  8. Human Reproductive Technologies Market, by End-User
  9. Americas Human Reproductive Technologies Market
  10. Asia-Pacific Human Reproductive Technologies Market
  11. Europe, Middle East & Africa Human Reproductive Technologies Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 290]
  16. List of Companies Mentioned [Total: 25]
Why More People Are Turning to Human Reproductive Technologies for Fertility Treatments
October 19, 2023
BLOG
Why More People Are Turning to Human Reproductive Technologies for Fertility Treatments
Gone are the days when couples who struggled with infertility were forced to accept their fate. Thanks to incredible advances in technology and medicine, human reproductive technologies (HRT) have made it possible for those previously deemed infertile to start a family. While these innovative treatments are nothing less than miraculous, what's more impressive is that they have led to a rise in medical tourism, where people travel worldwide to receive specialized fertility treatments.

Technological Advances in Human Reproductive Technologies:

Over the past decade, there have been significant breakthroughs in human reproductive technologies, allowing doctors to better diagnose and treat fertility issues. For instance, genetic testing can help identify embryo chromosomal abnormalities, allowing doctors to select the healthiest embryos for implantation. Moreover, advanced imaging platforms can help identify structural abnormalities or deficiencies affecting fertility rates.

Greater Affordability of HRT Treatments:

One of the reasons for the rising popularity of medical tourism and HRT treatments is the high cost of such treatments in developed countries. Therefore, couples are forced to travel to other countries for treatments that are much more affordable.

Success Rates:

Due to a combination of cutting-edge technology, medical expertise, and affordability, the success rates of HRT treatments continue to climb. Today, couples once told they were infertile can finally start a family. It's no wonder that medical tourism has been booming, with couples seeking out the best doctors and treatments worldwide to achieve their dreams of parenthood.

Ethical and Moral Considerations:

While HRT treatments have opened up a world of possibilities for infertile couples, they also have raised many ethical and moral issues, particularly in surrogacy and gender selection. Advocates have argued that these medical procedures can lead to intentional or unintentional discrimination and harm. As such, there is a need for continual dialogue, education, and advocacy as the industry continues to evolve.

Accessibility and Availability of Treatments:

With medical tourism, HRT treatments have become much more accessible and available to more people. More and more countries are offering medical visas and packages that cover travel, treatment, and post-treatment care, meaning those who were once unable to afford or access these treatments can now have a chance at starting a family.

Human reproductive technologies have changed the lives of countless couples who were once faced with the uncertainties of infertility. With advanced medical treatments and affordability, more and more people are turning to HRT to fulfill their dream of having a family. Medical tourism has made this possible for many people, allowing them to get the care they need at a price they can afford.

Frequently Asked Questions
  1. How big is the Human Reproductive Technologies Market?
    Ans. The Global Human Reproductive Technologies Market size was estimated at USD 29.84 billion in 2023 and expected to reach USD 31.82 billion in 2024.
  2. What is the Human Reproductive Technologies Market growth?
    Ans. The Global Human Reproductive Technologies Market to grow USD 46.89 billion by 2030, at a CAGR of 6.66%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.